Autocrine VEGF signaling promotes proliferation of neoplastic barrett's epithelial cells through a PLC-dependent pathway

Qiuyang D Zhang, Chunhua Yu, Sui Peng, Hao Xu, Ellen Wright, Xi Zhang, Xiaofang Huo, Edaire Cheng, Thai H Pham, Kiyotaka Asanuma, Kimmo J Hatanpaa, Davood Rezai, David H Wang, Venetia R Sarode, Shelby D Melton, Robert M Genta, Stuart J Spechler, Rhonda F Souza

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


Background & Aims Tumor cells express vascular endothelial growth factor (VEGF), which induces angiogenesis. VEGF also activates VEGF receptors (VEGFRs) on or within tumor cells to promote their proliferation in an autocrine fashion. We studied the mechanisms of autocrine VEGF signaling in Barrett's esophagus cells. Methods Using Barrett's epithelial cell lines, we measured VEGF and VEGFR messenger RNA and protein, and studied the effects of VEGF signaling on cell proliferation and VEGF secretion. We studied the effects of inhibiting factors in this pathway on levels of phosphorylated phospholipase Cγ1 (PLCG1), protein kinase C, and extracellular signal-regulated kinases (ERK)1/2. We performed immunohistochemical analysis of phosphorylated VEGFR2 on esophageal adenocarcinoma tissues. We studied effects of sunitinib, a VEGFR2 inhibitor, on proliferation of neoplastic cells and growth of xenograft tumors in mice. Results Neoplastic and non-neoplastic Barrett's cells expressed VEGF and VEGFR2 messenger RNA and protein, with higher levels in neoplastic cells. Incubation with recombinant human VEGF significantly increased secretion of VEGF protein and cell number; knockdown of PLCG1 markedly reduced the recombinant human VEGF-stimulated increase in levels of phosphorylated PLCG1 and phosphorylated ERK1/2 in neoplastic cells. Esophageal adenocarcinoma tissues showed immunostaining for phosphorylated VEGFR2. Sunitinib inhibited VEGF signaling in neoplastic cells and reduced weight and volume of xenograft tumors in mice. Conclusions Neoplastic and non-neoplastic Barrett's epithelial cells have autocrine VEGF signaling. In neoplastic Barrett's cells, VEGF activation of VEGFR2 initiates a PLCG1-protein kinase C-ERK pathway that promotes proliferation and is self-sustaining (by causing more VEGF production). Strategies to reduce autocrine VEGF signaling (eg, with sunitinib) might be used to prevent or treat cancer in patients with Barrett's esophagus.

Original languageEnglish (US)
Pages (from-to)461-472.e6
Issue number2
StatePublished - Feb 2014


  • Apoptosis
  • Esophageal Cancer
  • Mouse Model
  • Vascular Endothelial Growth Factor Receptor 2

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Autocrine VEGF signaling promotes proliferation of neoplastic barrett's epithelial cells through a PLC-dependent pathway'. Together they form a unique fingerprint.

Cite this